help_outline Skip to main content
Add Me To Your Mailing List
Organization of Regulatory and Clinical Associates
Contact Information:
Organization of Regulatory and Clinical Associates
P.O. Box 3490
Redmond, WA 98073
HomeCurrent/Future EventsWEBINAR - A Randomized Trial of Psilocybin-assisted Therapy for Doctors & Nurses

Current/Future Events - Event View

This is the "Event Detail" view, showing all available information for this event. If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.

WEBINAR - A Randomized Trial of Psilocybin-assisted Therapy for Doctors & Nurses

Feb 2023 Webinar graphic

An ORCA Lunch & Learn Webinar
NEW TIME ** 12:00 - 1:00 PM **

A Randomized Trial of Psilocybin-assisted Therapy for Doctors & Nurses

TOPIC DESCRIPTION: Dr. Anthony Back will discuss the emerging field of psychedelic therapy and the regulatory issues he encountered as an investigator new to this field.

SPEAKER: Anthony Back, M.D.

SPEAKER BIOGRAPHY: Dr. Anthony Back is Professor of Medicine at the University of Washington. He was educated at Stanford University and Harvard Medical School, and did his postgraduate medical training at the University of Washington in Seattle and the Fred Hutchinson Cancer Research Center.

Dr. Back's research into patient-oncologist communication, funded by the National Cancer Institute and numerous other foundations, led to founding of VitalTalk, a 501c3 with the mission of disseminating communication skill training to doctors and nurses who care for patients with a serious illness and their families. His work has been recognized by the American Cancer Society with the Pathfinder in Palliative Care Award, and by the American Society of Clinical Oncology with the first Walther Cancer Foundation Palliative and Supportive Care Award.

In 2018, Dr. Back turned his attention to psychedelic therapy, writing what remains the only first person account by a physician of a guided psychedelic experience to be published in a medical journal ("What Psilocybin Taught Me About Dying"). He is now conducting the first clinical trial of psilocybin-assisted therapy for doctors and nurses with symptoms of depression and burnout associated with their frontline work in the COVID pandemic, funded by the Steven and Alexandra Cohen Foundation

WHO: Clinical, regulatory, quality, manufacturing and legal

Attendance at this meeting may be applied as 1.0 point towards RAC re-certification

All attendees must be registered. Access to education content is a benefit of membership or guest attendance. The link to the webinar is intended for the registered person ONLY and any access/distribution of materials beyond the individual registrant is strictly prohibited. Viewing rights are not transferable and cannot be combined by multiple parties without express permission. Thank you for your understanding.
This webinar will be recorded.

Wednesday, February 15, 2023, 12:00 PM until 1:00 PM

Additional Info:
Event Contact(s):
ORCA Admin
Registration is closed
Payment In Full In Advance Only
RSVP by 9:00PM Tuesday, Feb 14, 2023

Meetings and webinars are scheduled on Pacific Standard Time or Pacific Daylight Time, whichever applies.

Please make sure that the following email address is in your Safe Sender list: System messages like meeting announcements, registration confirmations, webinar login instructions as well as certificates of attendance are sent directly from this email address.

You will receive the webinar login instructions in an email 2 days prior to the meeting date, or the night prior to the meeting if registering closer to the event. If you don't receive the instructions within this time frame, please contact us at as soon as possible.


For webinar events, payment is REQUIRED at the time of registration.
No Fee